The use of mutation-specific antibodies in predicting the effect of EGFR-TKIs in patients with non-small-cell lung cancer

Jingya Zhao(Fudan University), Xin Zhang(Fudan University), Haiying Zeng(Sun Yat-sen University), Qun Wang(Sun Yat-sen University), Xin Ye(Shandong University), Xiaoying Wang(Fudan University), Chen Xu(State University "Kyiv Aviation Institute"), Shaohua Lu(Sun Yat-sen University), Jie Huang(Sun Yat-sen University), Deming He(Fudan University), Qunying Hong(Sun Yat-sen University), Yun-shan Tan(Sun Yat-sen University), Yingyong Hou(Sun Yat-sen University), Guanshan Zhu(Shanghai Innovative Research Center of Traditional Chinese Medicine), Nuo Xu(Jilin University)
Journal of Cancer Research and Clinical Oncology
February 21, 2014
10.1007/s00432-014-1618-2
Cited by 15

Related Papers

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
|Cell|2019|1.2k
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
Neutrophil profiling illuminates anti-tumor antigen-presenting potency
|Cell|2024|436
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
|Journal of Clinical Oncology|2017|358